Compounds of Formula (IC) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT.sub.2 receptors in animals are described herein ##STR00001## .
This application is a divisional of U.S. patent application Ser. No. 10/156,884 filed on May 28, 2002 now U.S. Pat. No. 6,825,198 which claims the benefit of U.S. Provisional Ser. No. 60/299,953 filed Jun. 21, 2001 both of which are incorporated herein by reference in their entirety.
Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use thereof. More particularly, disclosed are inhibitors of Aurora A (Aurora-2) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.
